C5a decreases regional coronary blood flow and myocardial function in pigs: implications for a granulocyte mechanism.
- 1 August 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 63 (2) , 483-491
- https://doi.org/10.1161/01.res.63.2.483
Abstract
Granulocytes cause some of the pathophysiological effects associated with the capillary no-reflow phenomenon during ischemia and in ischemia-reperfusion injury. However, no study has examined the consequences of in vivo granulocyte activation during normal perfusion pressures. In this study, we examined the effects of intracoronary administration of the complement component C5a, which is known to be a potent granulocyte activating factor. Nine open-chest, anesthetized pigs were instrumented to monitor regional coronary blood flow and segment shortening, left ventricular dP/dt, heart rate, and pulmonary artery and aortic blood pressures and to sample arterial and regional coronary venous blood for oxygen content and complete blood counts. Intracoronary infusion of human or porcine C5a in doses ranging from 10 to 500 ng produced a significant reduction in regional coronary blood flow and myocardial function. Although perfusion pressure and heart rate remained constant, venous oxygen content fell, indicating an imbalance between myocardial oxygen supply and demand. In addition, the arteriovenous difference of white blood cells was increased significantly after anaphylatoxin infusion, indicating intravascular trapping in the myocardium. Granulocytes accounted entirely for the differences in leukocyte counts because no significant changes in platelet, lymphocyte, or hematocrit levels were observed. Injection of vehicle alone did not alter any of the monitored variables.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 40 references indexed in Scilit:
- C5a and Thromboxane Generation Associated with Pulmonary Vaso- and Broncho-constriction during Protamine Reversal of HeparinAnesthesiology, 1987
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Complement Ligand-Receptor Interactions that Mediate Biological ResponsesAnnual Review of Immunology, 1983
- Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassayFEBS Letters, 1982
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Quantitative comparisons of neutrophil chemotaxis in four animal speciesClinical Immunology and Immunopathology, 1980
- Oxygen-Dependent Microbial Killing by PhagocytesNew England Journal of Medicine, 1978
- Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.Journal of Clinical Investigation, 1977
- Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidaseJournal of Clinical Investigation, 1970
- NO REFLOW AFTER CEREBRAL ISCHÆMIAThe Lancet, 1967